title: Statins may protect against hepatocellular carcinoma development in patients infected with hepatitis C virus, but what are the mechanisms?
authors.affiliation: University Hospital, Geneva, Switzerland.
authors.forename: Sophie
authors.initials: S
authors.lastname: Clément
authors.forename: Marion
authors.initials: M
authors.lastname: Peyrou
authors.forename: Michelangelo
authors.initials: M
authors.lastname: Foti
authors.forename: Francesco
authors.initials: F
authors.lastname: Negro
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000209:etiology*; D005260:Female; D006526:Hepatitis C / Q000150:complications*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D008113:Liver Neoplasms / Q000209:etiology*; D008297:Male
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors